An advisory panel to the US Food and Drug Administration has determined there isn't enough data to gauge whether an Alzheimer's disease drug under investigation works, NPR reports.
An advisory panel to the US Food and Drug Administration has determined there isn't enough data to gauge whether an Alzheimer's disease drug under investigation works, NPR reports.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.